Konstantine Manouilov

Title: Innovations in Therapeutic Azide Compounds by Konstantine Manouilov

Introduction

Konstantine Manouilov is an accomplished inventor based in Omaha, NE (US). He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on therapeutic azide compounds. His research focuses on enhancing drug efficacy and delivery, which has important implications for medical treatments.

Latest Patents

Manouilov holds a patent for "Therapeutic azide compounds." This patent describes pharmaceutical prodrug compositions that include azide derivatives of drugs capable of being converted to the active drug in vivo. The azide derivatives, which feature amine, ketone, and hydroxy substituents, are designed to increase the half-life of the drugs. Notably, these azide prodrugs can penetrate the blood-brain barrier more effectively than their corresponding drugs. The patent highlights the utility of azide derivatives of various therapeutic compounds, including cordycepin, 2'-F-ara-ddI, AraA, acyclovir, and penciclovir.

Career Highlights

Throughout his career, Konstantine Manouilov has worked with prestigious institutions, including the University of Georgia Research Foundation Inc and Emory University. His research has contributed to advancements in drug development and therapeutic applications.

Collaborations

Manouilov has collaborated with notable colleagues such as Lakshmi Kotra and Raymond F Schinazi. These partnerships have further enriched his research and innovation in the pharmaceutical field.

Conclusion

Konstantine Manouilov's work on therapeutic azide compounds represents a significant advancement in pharmaceutical science. His innovative approach to drug delivery and efficacy continues to influence the development of new therapeutic options.